DAVIS A BRIAN 4
4 · Verrica Pharmaceuticals Inc. · Filed Aug 17, 2020
Insider Transaction Report
Form 4
DAVIS A BRIAN
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-08-13$6.24/sh+7,900$49,296→ 7,900 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.19 to $6.27 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.